US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
RSS Feeds

Biotechnology Industry Research & Market Reports

  2    4  5  6  7  8  9  10  
qPCR and dPCR Markets (Instruments, Reagents, Software/Services, Clinical and Research Markets)
10/22/2014 | published by: Kalorama Information
... is mainly a workhorse in the research laboratory, while dPCR is helping to push the potential for diagnostic applications due to its sensitivity, precision, robustness and reproducibility. qPCR has been established for a broad range ...  |  read more...
USD 4,200
Anti-CD279 (PD-1) Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... the understanding for all the pipeline drugs that fall under Anti-CD279 (PD-1) Antibody. This report provides information on the therapeutic development based on the Anti-CD279 (PD-1) Antibody dealing with mechanism of action, comparative analysis at ...  |  read more...
USD 1,250
Bioscience (UK) - Industry Report
11/5/2014 | published by: Plimsoll Publishing Ltd.
... – analysing the 240 largest Bioscience (UK) companies. The Bioscience (UK) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their unique and authoritative analysis. Indeed, the first section thoroughly scrutinises ...  |  read more...
USD 560
Biotechnology (UK) - Industry Report
11/5/2014 | published by: Plimsoll Publishing Ltd.
... – analysing the 120 largest Biotechnology (UK) companies. The Biotechnology (UK) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their unique and authoritative analysis. Indeed, the first section thoroughly scrutinises ...  |  read more...
USD 560
Medical & Scientific Research (European) - Industry Report
11/5/2014 | published by: Plimsoll Publishing Ltd.
... written and graphical analysis – analysing the 500 largest Medical & Scientific Research (European) companies. The Medical & Scientific Research (European) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their ...  |  read more...
USD 1,280
Proteomics (Global) - Industry Report
11/5/2014 | published by: Plimsoll Publishing Ltd.
... the 70 largest Proteomics (Global) companies. The Proteomics (Global) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their unique and authoritative analysis. Indeed, the first section thoroughly scrutinises the market ...  |  read more...
USD 1,520
Scientific Testing & Analysis (Nordic) - Industry Report
11/5/2014 | published by: Plimsoll Publishing Ltd.
... written and graphical analysis – analysing the 50 largest Scientific Testing & Analysis (Nordic) companies. The Scientific Testing & Analysis (Nordic) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their ...  |  read more...
USD 1,000
Anti-CD3 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD3 Antibody. This report provides information on the therapeutic development based on the Anti-CD3 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD38 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD38 Antibody. This report provides information on the therapeutic development based on the Anti-CD38 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD4 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD4 Antibody. This report provides information on the therapeutic development based on the Anti-CD4 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Baking Ingredients Market by Type (Enzymes, Emulsifiers, Leavening agents, Fats & Shortenings, Mold Inhibitors, Colors & Flavors), Application (Bread, Biscuits & Cookies, Cakes & Pastries, Rolls & Pies) & Region - Global Trends & Forecast to 2019
11/24/2014 | published by: MarketsandMarkets
... Forecast to 2019 Baking ingredients are widely used in baking applications such as bread, biscuits & cookies, cakes & pastries, rolls & pies, pizzas, donuts, and frozen baked products. These ingredients are used to enhance ...  |  read more...
USD 4,650
Biotechnology in the US - Industry Market Research Report
11/4/2014 | published by: IBISWorld
... aging population will drive solid revenue growth in the next five years. Furthermore, federal mandates will likely benefit the industry, leading to increases in research and development over the period. Firms in this industry primarily ...  |  read more...
USD 1,020
DNA & DNA Forensic Laboratories in the US - Industry Market Research Report
11/18/2014 | published by: IBISWorld
... common. Furthermore, the long-term trend of an increasing number of babies being born outside of wedlock has bolstered industry demand for DNA paternity testing. Looking forward, the industry is expected to continue growing, as improved ...  |  read more...
USD 1,020
Anti-CD40 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD40 Antibody. This report provides information on the therapeutic development based on the Anti-CD40 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Nocturia - Pipeline Review, H2 2014
11/14/2014 | published by: Global Markets Direct
... Nocturia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
ICON plc (ICLR) - Financial and Strategic SWOT Analysis Review
11/25/2014 | published by: GlobalData
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ...  |  read more...
USD 300
Anti-CD52 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD52 Antibody. This report provides information on the therapeutic development based on the Anti-CD52 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Antibodies in Oncology: Drug Pathway Analyzer 2014
11/4/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of more than 125 different tumor types. The rational for this plethora of treatment strategies is based on our increasing understanding of the 278 drug targets that are included ...  |  read more...
USD 6,746
Anti-CD6 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD6 Antibody. This report provides information on the therapeutic development based on the Anti-CD6 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Global Bone Cements Industry 2014 Market Research Report
11/20/2014 | published by: 9Dimen Research
... the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc. The report firstly introduced Bone Cements basic information including Bone Cements definition, classification, ...  |  read more...
USD 2,850
Anti-CD80 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD80 Antibody. This report provides information on the therapeutic development based on the Anti-CD80 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Celgene Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
11/24/2014 | published by: MarketLine
... Project Description: MarketLines' Celgene Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions ...  |  read more...
USD 350
Anti-CD95 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD95 Antibody. This report provides information on the therapeutic development based on the Anti-CD95 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
EFT BioTech Holdings Inc - Company Capsule
11/13/2014 | published by: Canadean Ltd
... key facts, major products and services, financial ratios, key competitors, financial analysis, key employees as well as company locations and subsidiaries. Summary This report is a crucial resource for industry executives and anyone looking to ...  |  read more...
USD 99
Anti-CS1 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CS1 Antibody. This report provides information on the therapeutic development based on the Anti-CS1 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
  2    4  5  6  7  8  9  10